DCF — WEIRTON MEDICAL CENTER
Enterprise Value: $142.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$142.4M
Enterprise Value
$37.3M
PV of Cash Flows
$105.1M
PV of Terminal Value
$169.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $187.9M | $18.5M | 10.0% | $7.1M | $6.5M |
| Year 2 | $193.5M | $21.0M | 11.0% | $8.8M | $7.3M |
| Year 3 | $199.3M | $23.7M | 12.0% | $10.6M | $7.9M |
| Year 4 | $205.3M | $25.4M | 12.0% | $11.6M | $8.0M |
| Year 5 | $211.4M | $26.7M | 13.0% | $12.4M | $7.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $142.4M. Terminal value accounts for 74% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$182.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.09371977231476177
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5